GILIO, LUANA
 Distribuzione geografica
Continente #
EU - Europa 313
NA - Nord America 302
AS - Asia 290
SA - Sud America 2
Totale 907
Nazione #
US - Stati Uniti d'America 283
SG - Singapore 174
DE - Germania 173
HK - Hong Kong 107
IT - Italia 87
CA - Canada 17
EE - Estonia 14
FI - Finlandia 8
RU - Federazione Russa 8
BE - Belgio 7
NL - Olanda 6
BD - Bangladesh 4
GB - Regno Unito 4
IL - Israele 3
BR - Brasile 2
ES - Italia 2
MX - Messico 2
AT - Austria 1
CH - Svizzera 1
IN - India 1
IR - Iran 1
LT - Lituania 1
PL - Polonia 1
Totale 907
Città #
Hong Kong 107
Falkenstein 88
Singapore 86
Frankfurt am Main 80
West Jordan 66
Rome 49
Chicago 45
Boardman 41
Ashburn 8
Helsinki 8
Moscow 8
Toronto 8
Brussels 7
Los Angeles 7
Buffalo 6
Ottawa 6
The Dalles 6
Charlotte 5
Bologna 4
San Francisco 4
Sant'Elpidio a Mare 4
Arosio 3
Ettlingen 3
Galbiate 3
Naples 3
New York 3
Amsterdam 2
Diano d'Alba 2
London 2
Mexico City 2
Montreal 2
Seattle 2
Turin 2
Zona Industriale 2
Boston 1
Brooklyn 1
Chennai 1
Council Bluffs 1
Dallas 1
Grellingen 1
Kiryat Ono 1
Milan 1
Santa Clara 1
São Paulo 1
Vila Velha 1
Warsaw 1
Totale 686
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 30
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 29
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 28
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 26
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 26
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 25
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 25
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 25
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 25
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 25
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 24
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 24
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 24
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 24
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 24
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 24
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 23
Osteopontin Is Associated with Multiple Sclerosis Relapses 23
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 23
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 23
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 23
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 22
Amyloid-β homeostasis bridges inflammation, synaptic plasticity deficits and cognitive dysfunction in multiple sclerosis 22
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 22
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 22
Obesity worsens central inflammation and disability in multiple sclerosis 22
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 21
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 21
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 21
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 21
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 19
Synaptic plasticity shapes brain connectivity: Implications for network topology 19
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 19
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 18
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 18
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 18
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 18
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 17
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 16
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 16
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 16
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 15
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 15
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis 14
Totale 980
Categoria #
all - tutte 9.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024219 0 0 0 0 0 0 52 0 0 137 15 15
2024/2025761 40 57 7 25 64 54 160 163 47 23 112 9
Totale 980